Conclusions: The cholesterol-dependent upregulation of LAP3 in hepatocytes plays a critical role in the pathogenesis of NAFLD via inhibiting autophagy. The gene discussed is LAP3; the disease is metabolic dysfunction-associated steatotic liver disease.